Cellectar Biosciences, Inc. (CLRB) vs Palatin Technologies, Inc. (PTN)
Cellectar Biosciences, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Cellectar Biosciences, Inc. is the larger, with a market value of $19.6M against $17.5M — 1.1× the size. Cellectar Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 2.4×. Cellectar Biosciences, Inc. has the higher net margin (0.00% vs −47.2%) and the higher return on invested capital (0.00% vs −942.3%). Across the 13 metrics below, Cellectar Biosciences, Inc. leads on 8 and Palatin Technologies, Inc. on 5.
Valuation
Profitability
| Metric | CLRB | PTN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (49.26%) | 0.00% |
| Net margin | 0.00% | (47.22%) | 0.00% |
| Free cash flow margin | 0.00% | (113.25%) | 0.00% |
| Return on equity | (125.99%) | (297.25%) | (57.72%) |
| Return on assets | (88.70%) | (73.72%) | (49.22%) |
| Return on invested capital | 0.00% | (942.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack